Kiadis Pharma NV (Kiadis Pharma NV) Accounts Payable & Accrued Expense : $17.78 Mil (As of Dec. 2020)

View and export this data going back to 2016. Start your Free Trial

What is Kiadis Pharma NV Accounts Payable & Accrued Expense?

Kiadis Pharma NV's quarterly accounts payable & accrued expense declined from Dec. 2019 ($5.84 Mil) to Jun. 2020 ($4.60 Mil) but then increased from Jun. 2020 ($4.60 Mil) to Dec. 2020 ($17.78 Mil).

Kiadis Pharma NV's annual accounts payable & accrued expense increased from Dec. 2018 ($3.03 Mil) to Dec. 2019 ($5.84 Mil) and increased from Dec. 2019 ($5.84 Mil) to Dec. 2020 ($17.78 Mil).

Kiadis Pharma NV Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kiadis Pharma NV's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Accounts Payable & Accrued Expense Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.71

2.12

3.03

5.84

17.78

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial											3.03	4.76	5.84	4.60	17.78

Kiadis Pharma NV Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kiadis Pharma NV (Kiadis Pharma NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (GREY:KIADF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (Kiadis Pharma NV) Headlines

No Headlines